Rémi Gaston-Dreyfus, is an independent entrepreneur and investor.
He started as a lawyer at the Paris Bar and cofounded his business law firm – Gaston-Dreyfus, Le Douarin, Servan-Schreiber & Veil – in 1984.
In 1992, he took part in the launch of his first biotechnology startup in the field of horticulture, creating the Tamaya indoor tree flowers.
In 2000, as a shareholder and chairman for the photojournalism group A.G.I., he supervised the restructuring and divestiture of the group to Hachette-Filipacchi-Lagardère.
Since 2006, he acts as chairman of his own investment firm, GDG Investments, specializing in restructuring obsolete assets in the wider Paris region.
He sits at the board of several companies, including Bionik Laboratories, a listed company on OTC market, focusing on pioneering robotics to
provide rehabilitation solutions to individuals with neurological disorders such as CVA and exoskeleton.
